OTOV-401

N/A

Report date: 2023/10/12 15:40:21

Base Information

Drug NameOTOV-401
Drug Alias NameOTOV-401OTOV-401 基因治疗耳毛细胞再生
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionGene transference
TargetsNot applicable
Therapy Area/IndicationsHearing Loss, Sensorineural
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSuzhou Otovia Therapeutics Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Otovia Therapeutics Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsHearing Loss, Sensorineural
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A